Houston Methodist Neurological Institute researchers from the department of neurosurgery shrunk a deadly glioblastoma tumor by more than a third using a helmet generating a noninvasive oscillating magnetic field that the patient wore on his head while administering the therapy in his own home. The 53-year-old patient died from an unrelated injury about a month into the treatment, but during that short time, 31% of the tumor mass disappeared. The autopsy of his brain confirmed the rapid response to the treatment.
“Thanks to the courage of this patient and his family, we were able to test and verify the potential effectiveness of the first noninvasive therapy for glioblastoma in the world,” said David S. Baskin, M.D., FACS, FAANS, corresponding author and director of the Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment in the Department of Neurosurgery at Houston Methodist. “The family’s generous agreement to allow an autopsy after their loved ones’ untimely death made an invaluable contribution to the further study and development of this potentially powerful therapy.”
In a case study published in Frontiers in Oncology Baskin and his colleagues detailed the journey of their pioneering patient who suffered from end-stage recurrent glioblastoma, despite a radical surgical excision, chemoradiotherapy and experimental gene therapy.
Glioblastoma is the deadliest of brain cancers in adults, nearly always fatal, with a life expectancy of a few months to two years. When the patient’s glioblastoma recurred in August 2019, Baskin and his team, already working on the OMF treatment in mouse models, received FDA approval for compassionate use treatment of the patient with their newly invented Oncomagnetic Device under an Expanded Access Program (EAP). The protocol also was approved by the Houston Methodist Research Institute Institutional Review Board.
The treatment consisted of intermittent application of an oscillating magnetic field generated by rotating permanent magnets in a specific frequency profile and timing pattern. First administered for two hours under supervision in the Peak Clinic, ensuing treatments were given at home with help from the patient’s wife, with increasing treatment times up to a maximum of only six hours per day.
The Oncomagnetic Device looks deceptively simple: three oncoscillators securely attached to a helmet and connected to a microprocessor-based electronic controller operated by a rechargeable battery, an invention by case study co-author Dr. Santosh Helekar. During the patient’s five weeks of treatment, the magnetic therapy was well-tolerated and the tumor mass and volume shrunk by nearly a third, with shrinkage appearing to correlate with the treatment dose.
“Imagine treating brain cancer without radiation therapy or chemotherapy,” said Baskin. “Our results in the laboratory and with this patient open a new world of non-invasive and nontoxic therapy for brain cancer, with many exciting possibilities for the future.”
Original Article: INVESTIGATIONAL MAGNETIC DEVICE SHRINKS GLIOBLASTOMA IN FIRST-IN-WORLD HUMAN TEST
More from: Houston Methodist Hospital
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Glioblastoma
- Glioblastoma Pipeline Landscape Report 2024: Pivotal Advances in Treatment Protocols and Drug Developments
The "Glioblastoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest report on the Glioblastoma pipeline insights covers extensive research into the ...
- New Therapy Destroys Deadly Brain Tumor in Days
A groundbreaking new therapy destroys deadly brain tumors within days. The new treatment, CAR T-cell therapy, helps treat glioblastoma.
- Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion ...
- ITM, Helmholtz Munich and University Hospital Münster Announce First Patient Dosed in Phase I Investigator-Initiated Glioblastoma Trial
ITM-31 is a carbonic anhydrase (CA) XII-specific antibody Fab fragment developed by Helmholtz Munich and coupled with ITM's medical radioisotope, non-carrier-added Lutetium-177 (n.c.a. 177 Lu, ...
- Genetically engineering a treatment for incurable brain tumors
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 ...
Go deeper with Google Headlines on:
Glioblastoma
[google_news title=”” keyword=”glioblastoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Oscillating magnetic field
- Researchers Teach Old Artificial Hairs New Tricks
“The reprogramming step is fairly straightforward,” Tracy said. “We apply an oscillating field to reset the magnetization, then apply a strong magnetic field to the cilia which allows us to magnetize ...
- Researchers show it's possible to teach old magnetic cilia new tricks
Magnetic cilia—artificial hairs whose movement is powered by embedded magnetic particles—have been around for a while, and are of interest for applications in soft robotics, transporting objects and ...
- A Paradigm Shift in RAM Is About to Make Computing Unstoppable
For more than two decades, the most advanced version of this technology—magnetoresistive RAM, or MRAM—has been the go-to tech for the kind of intense computing necessary in industrial, military, and ...
- Magnetic levitation: New material offers potential for unlocking gravity-free technology
The biggest limiting factor is 'eddy damping', which occurs when an oscillating system loses energy over time because of external forces. When an electrical conductor, like graphite, passes through a ...
- Magnetic levitation: New material offers potential for unlocking gravity-free technology
When an external magnetic field is applied to 'diamagnetic' materials ... The biggest limiting factor is 'eddy damping', which occurs when an oscillating system loses energy over time because ...
Go deeper with Google Headlines on:
Oscillating magnetic field
[google_news title=”” keyword=”oscillating magnetic field” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]